What is Retatrutide and how is it different from GLP-1–only compounds?

retatrutideglp1gipglucagonmetabolicpopular

Retatrutide is studied as a multi-agonist with activity at GLP-1, GIP, and glucagon receptors. Research interest often centers on multi-receptor metabolic signaling and how it differs from single- or dual-agonist approaches.

Research use only. Not medical advice.

For research use only. Not medical advice.

Related questions

Browse all FAQs about research peptides, sourcing, and Peptide Library.

View all FAQs